Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria R Parkhurst

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Cancer Cell|April 10, 2023
Adoptive cell transfer immunotherapy for patients with solid epithelial cancersSteven A Rosenberg, Maria R Parkhurst, Paul F Robbins
Journal of Immunological Methods|May 10, 2003
Stimulation of tumor-reactive T lymphocytes using mixtures of synthetic peptides derived from tumor-associated antigens with diverse MHC binding affinitiesJohn P Riley, Steven A Rosenberg, Maria R Parkhurst
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 8, 2001
Identification of a New Shared HLA-A2.1 Restricted Epitope From the Melanoma Antigen TyrosinaseJohn P. Riley, Steven A. Rosenberg, Maria R. Parkhurst
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant proteinMaria R Parkhurst, John P Riley, Paul F Robbins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regressionMaria R Parkhurst, John P Riley, Mark E Dudley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II moleculesMaria R Parkhurst, Cormac DePan, John P Riley, et al.
Journal of Translational Medicine|April 6, 2012
Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactorRobert P T Somerville, Laura Devillier, Maria R Parkhurst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomeraseMaria R Parkhurst, John P Riley, Takehito Igarashi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2006
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectorsMichal Lotem, Yangbing Zhao, John Riley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cellsMaria R Parkhurst, Jayne Joo, John P Riley, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Cancer Cell|April 10, 2023
Adoptive cell transfer immunotherapy for patients with solid epithelial cancersSteven A Rosenberg, Maria R Parkhurst, Paul F Robbins
Journal of Immunological Methods|May 10, 2003
Stimulation of tumor-reactive T lymphocytes using mixtures of synthetic peptides derived from tumor-associated antigens with diverse MHC binding affinitiesJohn P Riley, Steven A Rosenberg, Maria R Parkhurst
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 8, 2001
Identification of a New Shared HLA-A2.1 Restricted Epitope From the Melanoma Antigen TyrosinaseJohn P. Riley, Steven A. Rosenberg, Maria R. Parkhurst
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant proteinMaria R Parkhurst, John P Riley, Paul F Robbins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regressionMaria R Parkhurst, John P Riley, Mark E Dudley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II moleculesMaria R Parkhurst, Cormac DePan, John P Riley, et al.
Journal of Translational Medicine|April 6, 2012
Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactorRobert P T Somerville, Laura Devillier, Maria R Parkhurst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomeraseMaria R Parkhurst, John P Riley, Takehito Igarashi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2006
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectorsMichal Lotem, Yangbing Zhao, John Riley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cellsMaria R Parkhurst, Jayne Joo, John P Riley, et al.
Pageof 5